{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:38:37Z","timestamp":1792651117353,"version":"4.5.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00372","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T05:17:56Z","timestamp":1584422276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":200,"title":["Vaccine Safety: Myths and Misinformation"],"prefix":"10.3389","volume":"11","author":[{"given":"Sarah","family":"Geoghegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Offit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.vaccine.2018.02.034","article-title":"Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.","volume":"36","author":"Arana","year":"2018","journal-title":"Vaccine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.","volume":"347","author":"Arnheim-Dahlstrom","year":"2013","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.vaccine.2017.02.049","article-title":"Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: results from prospective cohort data.","volume":"35","author":"Beyerlein","year":"2017","journal-title":"Vaccine"},{"key":"B4","year":"2019","journal-title":"HPV Vaccination is Safe and Effective."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1016\/j.vaccine.2017.05.041","article-title":"Maternal Tdap vaccination and risk of infant morbidity.","volume":"35","author":"DeSilva","year":"2017","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.2016.14432","article-title":"Tdap vaccination during pregnancy and microcephaly and other structural birth defects in offspring.","volume":"316","author":"DeSilva","year":"2016","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1016\/j.vaccine.2019.09.035","article-title":"Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.","volume":"37","author":"Donahue","year":"2019","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jama.2018.0708","article-title":"Association between estimated cumulative vaccine antigen exposure through the first 23 months of life and non-vaccine-targeted infections from 24 through 47 months of age.","volume":"319","author":"Glanz","year":"2018","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/aje\/kws195","article-title":"Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.","volume":"175","author":"Greene","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067185","article-title":"Guillain-Barre Syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011.","volume":"8","author":"Greene","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaut.2017.01.005","article-title":"Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance.","volume":"79","author":"Grimaldi-Bensouda","year":"2017","journal-title":"J. Autoimmun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study.","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"key":"B13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.15585\/mmwr.mm6535a3","article-title":"Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine \u2013 worldwide.","volume":"2016","author":"Hampton","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/S1473-3099(17)30232-3","article-title":"Group B Streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.","volume":"17","author":"Heath","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.294.6.699","article-title":"Childhood vaccination and nontargeted infectious disease hospitalization.","volume":"294","author":"Hviid","year":"2005","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/pds.3482","article-title":"Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years.","volume":"22","author":"Iqbal","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.acap.2017.09.003","article-title":"Blood and hair aluminum levels, vaccine history, and early infant development: a cross-sectional study.","volume":"18","author":"Karwowski","year":"2018","journal-title":"Acad. Pediatr."},{"key":"B18","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0264-410X(02)00165-2","article-title":"Aluminum toxicokinetics regarding infant diet and vaccinations.","author":"Keith","year":"2002","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/AOG.0b013e3182a1118a","article-title":"Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events.","volume":"122","author":"Kharbanda","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jpeds.2017.04.039","article-title":"First trimester influenza vaccination and risks for major structural birth defects in offspring.","volume":"187","author":"Kharbanda","year":"2017","journal-title":"J. Pediatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1473-3099(13)70104-X","article-title":"Risk of Guillain-Barre syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.","volume":"13","author":"Kwong","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.","volume":"32","author":"Larson","year":"2014","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1016\/j.vaccine.2017.06.071","article-title":"Prenatal Tdap immunization and risk of maternal and newborn adverse events.","volume":"35","author":"Layton","year":"2017","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.15585\/mmwr.mm6840e1","article-title":"Vital signs: burden and prevention of influenza and pertussis among pregnant women and infants \u2013 United States.","volume":"68","author":"Lindley","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa021134","article-title":"A population-based study of measles, mumps, and rubella vaccination and autism.","volume":"347","author":"Madsen","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and multiple sclerosis: a systematic review.","volume":"264","author":"Mailand","year":"2017","journal-title":"J. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain-Barre syndrome and influenza vaccines: a meta-analysis.","volume":"33","author":"Martin Arias","year":"2015","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults.","volume":"137","author":"McNeil","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9538","DOI":"10.1016\/j.vaccine.2011.09.124","article-title":"Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.","volume":"29","author":"Mitkus","year":"2011","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00125-015-3800-8","article-title":"Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies.","volume":"59","author":"Morgan","year":"2016","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.vaccine.2018.02.036","article-title":"Hepatitis B vaccination and the putative risk of central demyelinating diseases \u2013 a systematic review and meta-analysis.","volume":"36","author":"Mouchet","year":"2018","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1542\/peds.2008-2189","article-title":"The problem with Dr Bob\u2019s alternative vaccine schedule.","volume":"123","author":"Offit","year":"2009","journal-title":"Pediatrics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/peds.109.1.124","article-title":"Addressing parents\u2019 concerns: do multiple vaccines overwhelm or weaken the infant\u2019s immune system?","volume":"109","author":"Offit","year":"2002","journal-title":"Pediatrics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1542\/peds.2010-0309","article-title":"Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.","volume":"126","author":"Price","year":"2010","journal-title":"Pediatrics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the history of smallpox and vaccination.","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc. Bayl. Univ. Med. Cent."},{"key":"B36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/pr.2016.272","article-title":"Lack of broad functional differences in immunity in fully vaccinated vs. unvaccinated children.","volume":"81","author":"Sherrid","year":"2017","journal-title":"Pediatr. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.1016\/j.vaccine.2018.06.074","article-title":"The association of adverse events with bivalent human papilloma virus vaccination: a nationwide register-based cohort study in Finland.","volume":"36","author":"Skufca","year":"2018","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1016\/j.vaccine.2017.09.046","article-title":"A systematic review of factors affecting vaccine uptake in young children.","volume":"35","author":"Smith","year":"2017","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1542\/peds.2009-2489","article-title":"On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes.","volume":"125","author":"Smith","year":"2010","journal-title":"Pediatrics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/jama.2015.12790","article-title":"Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations.","volume":"314","author":"Sukumaran","year":"2015","journal-title":"JAMA"},{"key":"B41","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(99)01239-8","article-title":"Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1542\/peds.2008-0795","article-title":"Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.","volume":"123","author":"Tozzi","year":"2009","journal-title":"Pediatrics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0140-6736(97)11096-0","article-title":"Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/biol.1995.0036","article-title":"Administration of tumor cell chromatin to immunosuppressed and non-immunosuppressed non-human primates.","volume":"23","author":"Wierenga","year":"1995","journal-title":"Biologicals"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6420","DOI":"10.1016\/j.vaccine.2015.08.046","article-title":"Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review.","volume":"33","author":"Wilson","year":"2015","journal-title":"Vaccine"},{"key":"B46","year":"2019","journal-title":"Immunization, Vaccines and Biologicals: WHO Recommendations for Routine Immunization \u2013 Summary Tables."},{"key":"B47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5731\/pdajpst.2013.00910","article-title":"Establishing acceptable limits of residual DNA.","volume":"67","author":"Yang","year":"2013","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1016\/j.vaccine.2017.04.074","article-title":"No association between influenza vaccination during pregnancy and adverse birth outcomes.","volume":"35","author":"Zerbo","year":"2017","journal-title":"Vaccine"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00372\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T05:17:58Z","timestamp":1584422278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00372\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":48,"alternative-id":["10.3389\/fmicb.2020.00372"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00372","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"article-number":"372"}}